The ARHGEF4 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human embryonic kidney cell line HEK293T. This product features targeted disruption of the ARHGEF4 gene, which encodes a Rho guanine nucleotide exchange factor (GEF) critical for activating Rho family GTPases. The polyclonal pool is generated via CRISPR/Cas9-mediated gene disruption in the HEK293T background, providing a genetically heterogeneous population suitable for studying the functional consequences of ARHGEF4 loss without clonal selection artifacts. The knockout model enables investigation of ARHGEF4-dependent signaling pathways in a widely used cellular context.
The HEK293T cell line is a derivative of HEK293 human embryonic kidney cells, immortalized by adenovirus 5 DNA. These cells exhibit epithelial morphology and high transfectability, making them ideal for protein expression and signaling studies. The embryonic kidney origin provides a neutral background for analyzing basic cellular processes. The CRISPR/Cas9-edited polyclonal knockout population retains the growth and manipulation ease of the parental line, while enabling dissection of ARHGEF4-mediated functions.
ARHGEF4 functions as a GEF that catalyzes the exchange of GDP for GTP on Rho family GTPases, including RhoA, Rac1, and Cdc42, thereby activating these molecular switches. Activation occurs downstream of extracellular cues such as growth factor receptors and integrin-mediated adhesion, linking extracellular matrix interactions to intracellular actin dynamics. ARHGEF4 cooperates with the adenomatous polyposis coli (APC) protein and microtubules to spatially regulate Rho GTPase activation. Subsequent signaling through downstream effectors like PAK and cofilin drives actin cytoskeletal reorganization, facilitating cell migration and adhesion. The mechanistic summary highlights that ARHGEF4 knockout is expected to impair Rho-mediated signaling, leading to altered cytoskeletal dynamics and reduced migratory capacity.
In the HEK293T background, ARHGEF4 knockout provides a loss-of-function model that is valuable for dissecting Rho GTPase signaling cascades. The epithelial nature of HEK293T cells, combined with their robust growth and transfection proficiency, makes them suitable for imaging-based studies of actin dynamics, migration assays, and biochemical analyses of GTPase activation. This polyclonal population allows researchers to study the average phenotypic effects of ARHGEF4 disruption, avoiding potential clonal biases. The model is particularly relevant for investigating the gene’s role in processes deregulated in colorectal cancer and neurodegenerative disorders, where Rho signaling and cytoskeletal integrity are often compromised.
Researchers can employ this knockout cell population in diverse functional studies, including western blotting to assess downstream effector phosphorylation, immunofluorescence microscopy to visualize actin stress fiber organization, and transwell migration or scratch wound assays to quantify cell motility. Rho GTPase activation can be monitored using pull-down assays with GST-tagged effector binding domains, enabling direct measurement of RhoA, Rac1, or Cdc42 activity. These cells are also suited for co-culture experiments, drug response profiling, and genetic rescue studies by re-expressing wild-type or mutant ARHGEF4. For additional technical specifications or batch-specific data, please contact Ascent Research.
